| Edit |   |
|---|
| Antigenic Specificity | C-terminal domain of P300/CBP-Associated Factor (Human PCAF) |
|---|
| Clone | 2G3/H8 |
|---|
| Host Species | Mouse |
|---|
| Reactive Species | n/a |
|---|
| Isotype | n/a |
|---|
| Format | purified IgG fraction |
|---|
| Size | 150 μg |
|---|
| Concentration | n/a |
|---|
| Applications | applications: This antibody can be used for ELISA assay (1:8,000 dilution) and Western Blot. It recognizes the N-terminal domain of the transcriptional activator PCAF. This domain of PCAF contains a region that interacts with p300/CBP and it competes with the adenoviral E1A oncoprotein for binding to p300/CBP as a potential tumor suppressor.Formulation: Solution at 1.0 mg/ml in PBS. |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Product Specifications Anti N-terminal domain of P300/CBP-Associated Factor(human PCAF). IgG fraction (monoclonal): Description: IgG fraction from mouse monoclonal antibody (clone 2G3/H8) obtained by immunization of mice with the N-terminal domain of human PCAF. The IgG fraction was purified using Protein G-Sepharose.Isotype: IgG2a.Storage: Store at -20°C.Stability: Stable for at least one year. Avoid repeated freezing and thawing.Applications: This antibody can be used for ELISA assay (1:8,000 dilution) and Western Blot. It recognizes the N-terminal domain of the transcriptional activator PCAF. This domain of PCAF contains a region that interacts with p300/CBP and it competes with the adenoviral E1A oncoprotein for binding to p300/CBP as a potential tumor suppressor.Formulation: Solution at 1.0 mg/ml in PBS. |
|---|
| Immunogen | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession # | n/a |
|---|
| Catalog # | TM-711BY-55 |
|---|
| Price | |
|---|
| Order / More Info | C-terminal domain of P300/CBP-Associated Factor (Human PCAF) Antibody from IMMUNOLOGICAL & BIOCHEMICAL TESTSYSTEMS GmbH |
|---|
| Product Specific References | n/a |
|---|